Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase 2 5Phase NA 3Phase 4 1Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1

Conditions

Gastrointestinal Stromal Tumors 10Bone Neoplasms 9Sarcoma 8Neoplasms 3Multiple Myeloma 3Sarcoma, Kaposi 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Osteosarcoma 2Neoplasm Metastasis 2Lymphoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Anemia 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Renal Insufficiency 1Recurrence 1Rectal Neoplasms 1Psoriasis 1Prostatic Neoplasms 1Progressive Gastrointestinal Stromal Tumor 1Piebaldism 1Pancreatic Neoplasms 1Pain, Intractable 1

Interventions

Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Anus Neoplasms × Sarcoma × Clear all
NCT00274885 2011-12-05

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

National Cancer Institute (NCI)

Phase 4 Unknown
58 enrolled
GastrointestinalSarcoma

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neurotoxicity Syndromes, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡